drugset / Trial / NCT01731327
A Phase 1 Study To Evaluate The Pharmacokinetics (PK), Safety, And Bioavailability Of A Modified-Release (MR) Formulation Of Tofacitinib In Healthy Volunteers
RandomizedCrossoverOpen-labelBasic science
Summary
This study will explore the drug behavior and safety following single doses of tofacitinib modified-release (MR) 11 mg and MR 22 mg in healthy volunteers.
Timeline
- Start
- 2012-11
- Primary completion
- 2012-12
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tofacitinib | Small molecule | 11 mg | Oral |
| Subject | Tofacitinib | Small molecule | 22 mg | Oral |
Indications
No indication recorded.